Hematologic Diseases
"Hematologic Diseases" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disorders of the blood and blood forming tissues.
Descriptor ID |
D006402
|
MeSH Number(s) |
C15.378
|
Concept/Terms |
Hematologic Diseases- Hematologic Diseases
- Disease, Hematologic
- Diseases, Hematologic
- Hematologic Disease
- Blood Diseases
- Blood Disease
- Disease, Blood
- Diseases, Blood
- Hematological Diseases
- Disease, Hematological
- Diseases, Hematological
- Hematological Disease
|
Below are MeSH descriptors whose meaning is more general than "Hematologic Diseases".
Below are MeSH descriptors whose meaning is more specific than "Hematologic Diseases".
This graph shows the total number of publications written about "Hematologic Diseases" by people in UAMS Profiles by year, and whether "Hematologic Diseases" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2021 | 1 | 0 | 1 | 2019 | 1 | 0 | 1 | 2018 | 1 | 0 | 1 | 2016 | 0 | 1 | 1 | 2015 | 2 | 0 | 2 | 2014 | 0 | 1 | 1 | 2013 | 1 | 0 | 1 | 2010 | 0 | 1 | 1 | 2009 | 2 | 1 | 3 | 2007 | 0 | 1 | 1 | 2006 | 1 | 0 | 1 | 2004 | 0 | 1 | 1 | 2001 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hematologic Diseases" by people in Profiles over the past ten years.
-
Furutani E, Liu S, Galvin A, Steltz S, Malsch MM, Loveless SK, Mount L, Larson JH, Queenan K, Bertuch AA, Fleming MD, Gansner JM, Geddis AE, Hanna R, Keel SB, Lau BW, Lipton JM, Lorsbach R, Nakano TA, Vlachos A, Wang WC, Davies SM, Weller E, Myers KC, Shimamura A. Hematologic complications with age in Shwachman-Diamond syndrome. Blood Adv. 2022 01 11; 6(1):297-306.
-
Yarlagadda N, Gundarlapalli S, Sharma S, Suelzer E, Abid MB, Abdallah AO, Schinke C, Atrash S, Mohan M. Hematological and infectious complications with CD38 antigen targeting monoclonal antibody-based therapies in multiple myeloma: A meta-analysis of randomized control trials. Leuk Res. 2021 11; 110:106714.
-
Lee MO, Park J, Park EY, Kim Y, Bang E, Heo S, Kim J. The Korean-Advance Directive Model and Factors Associated With Its Completion Among Patients With Hematologic Disorders. J Hosp Palliat Nurs. 2019 08; 21(4):E10-E16.
-
Cheng WY, Said Q, Hao Y, Xiao Y, Vekeman F, Bobbili P, Duh MS, Nandal S, Blinder M. Adherence to iron chelation therapy in patients who switched from deferasirox dispersible tablets to deferasirox film-coated tablets. Curr Med Res Opin. 2018 11; 34(11):1959-1966.
-
McCaleb RV, Gandhi AS, Clark SM, Clemmons AB. Clinical Outcomes of Acid Suppressive Therapy Use in Hematology/Oncology Patients at an Academic Medical Center. Ann Pharmacother. 2016 07; 50(7):541-7.
-
Lindsley AW, Saal HM, Burrow TA, Hopkin RJ, Shchelochkov O, Khandelwal P, Xie C, Bleesing J, Filipovich L, Risma K, Assa'ad AH, Roehrs PA, Bernstein JA. Defects of B-cell terminal differentiation in patients with type-1 Kabuki syndrome. J Allergy Clin Immunol. 2016 Jan; 137(1):179-187.e10.
-
Tai R, Tirumani SH, Tirumani H, Shinagare AB, Hornick JL, Ramaiya NH. Is there a difference in post-transplant lymphoproliferative disorder in adults after solid organ and haematologic stem cell transplantation? Experience in 41 patients. Br J Radiol. 2015 Aug; 88(1052):20140861.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|